The PIL has argued that lifting the price cap with lead to windfall gains for pharma companies and that removing the price cap is unconstitutional against public interest.
first published: Oct 9, 2014 04:36 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Bulls Likely To Tread With Caution With Eye On Axis Bank Q2 Earnings |Opening Bell Live
Live: Nifty slips below 25,200, LG Electronics shares down after blockbuster debut | Closing Bell
Why markets haven’t delivered and why they will turn now
Nifty Upmove Hinges On Quarterly Earnings; Will LG Electronics See A Listing Pop?|Opening Bell Live
